Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares Outstanding (Weighted Average)
Others
Ratios

Genprex (GNPX) EBIT (2016 - 2025)

Genprex (GNPX) has 9 years of EBIT data on record, last reported at -$3.3 million in Q3 2025.

  • For Q3 2025, EBIT rose 22.61% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached -$16.3 million, up 28.39%, while the annual FY2024 figure was -$21.2 million, 31.82% up from the prior year.
  • EBIT reached -$3.3 million in Q3 2025 per GNPX's latest filing, up from -$4.7 million in the prior quarter.
  • Across five years, EBIT topped out at -$3.3 million in Q3 2025 and bottomed at -$9.3 million in Q1 2023.
  • Average EBIT over 5 years is -$5.7 million, with a median of -$5.8 million recorded in 2022.
  • Peak YoY movement for EBIT: plummeted 79.43% in 2022, then surged 44.47% in 2024.
  • A 5-year view of EBIT shows it stood at -$6.8 million in 2021, then increased by 2.56% to -$6.6 million in 2022, then increased by 9.29% to -$6.0 million in 2023, then grew by 27.35% to -$4.3 million in 2024, then increased by 22.83% to -$3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$3.3 million in Q3 2025, -$4.7 million in Q2 2025, and -$4.0 million in Q1 2025.